Rick Wise

Intuitive Surgical Posts Q3 Earnings Beat, These Analysts Raise Forecasts On DV5 Uptake

Intuitive Surgical's Q2 Performance Lauded By Bullish Analysts

LivaNova Valuation Multiples Likely to Increase Amid Steady Progress, Stifel Says In Bullish Initiation

Intuitive Surgical's Q2 Performance Lauded By Bullish Analysts

LivaNova Valuation Multiples Likely to Increase Amid Steady Progress, Stifel Says In Bullish Initiation

LeMaitre Vascular's Lack Of Near-Term Catalysts Pushes Stifel To The Sidelines

Zimmer Biomet Shares Are Better Positioned To Outperform; Stifel Upgrades

LeMaitre Vascular's Lack Of Near-Term Catalysts Pushes Stifel To The Sidelines

Zimmer Biomet Shares Are Better Positioned To Outperform; Stifel Upgrades

OrthoPediatrics Could Win By Tapping A Massive, Underserved Market, Says Stifel

How Surgeons Are Responding To TransEnterix's Senhance Following FDA Approval

Rick Wise Recent News

FDA Approval For Endologix's Nellix Likely Pushed To At Least 2020

UPDATE: Stifel Reiterates On TriVascular Technologies Following 3Q14 Sales Results

Stifel Lays Out The Bull Case For Intuitive Surgical

UPDATE: Stifel Initiates Coverage On LeMaitre Vascular On Good Investment Opportunity

UPDATE: Stifel Initiates Coverage on Tandem Diabetes Care on Multiple Growth Drivers

UPDATE: Stifel Nicolaus Initiates Endologix at Buy on Compelling Growth

Medtronic, Inc. (MDT) Maintains Market Perform Rating

Volcano Corporation’s (VOLC) Fourth-Quarter Review